The pharmaceutical industry has been confronted over the years with three decisive events that have shaped its current appearance: Ever more complex molecules, a series of patent expirations of high-revenue drivers and, linked to this, a growing market for me-too, generic products. These events respectively created a shift of needs among the market players.

Thus MCS founded its operative and strategic business activities in 2001.

MCS understands the market needs to provide client services blending science, engineering and counseling know-how necessary to take customers pharmaceutical products to the market, and to anticipate and satisfy drug consumers present and future therapeutic needs on a sustainable basis.

Today, MCS operates on an independent financial basis, free of debt and venture capital. This allows MCS to be a stand-alone organization, free from third tier interests with full operational strength.

This philosophy has allowed MCS to promote itself across some 25 major projects over its years of market presence and build-up a reputation of expertise in the field of drug development.